Ogsiveo

Active Ingredient(s): Nirogacestat
FDA Approved: * November 27, 2023
Pharm Company: * SPRINGWORKS THERAPEUTICS INC
Category: Cancer
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Ogsiveo 50 mg Oral Tablet, Film Coated
NDC: 82448-050
Labeler:
Springworks Therapeutics, Inc.
Ogsiveo 100 mg Oral Tablet, Film Coated
NDC: 82448-100
Labeler:
Springworks Therapeutics, Inc.
Ogsiveo 150 mg Oral Tablet, Film Coated
NDC: 82448-150
Labeler:
Springworks Therapeutics, Inc.